What to expect from Aldawaa’s Q4 2024 earnings?
In this report, Argaam highlights the expected results of Aldawaa Medical Services Co. for the fourth quarter of 2024, as well as its key events, sales, earnings, and performance indicators.
The fourth-quarter revenue is forecast to rise by 8.04% year-on-year (YoY) to SAR 1.57 billion.
Quarter Revenue Changes (M Riyal)
Item | Q4 2023 |
Q1 2024 |
Q2 2024 |
Q3 2024 |
Q4 2024 (Average Estimate) |
---|---|---|---|---|---|
Sales | 1,458.09 | 1,516.42 | 1,586.27 | 1,626.23 | 1,575.33 |
Change % | (0.01%) | 7.73% | 10.41% | 13.02% | 8.04% |
Quarter Net Income Changes (M Riyal)
Item | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 (Average Estimate) |
---|---|---|---|---|---|
Net Income | 92.35 | 95.33 | 95.88 | 75.09 | 86.13 |
Extraordinary income/expense | 0.00 | 0.00 | 0.00 | 0.00 | - |
Net Profit Before Unusual Items | 92.35 | 95.33 | 95.88 | 75.09 | - |
EPS Before Unusual Items (Riyal/Share) | 1.09 | 1.12 | 1.13 | 0.88 | 1.01 |
Quarterly Profit and Revenue (M Riyal)
Average Estimates
Aldawaa’s net profit is expected to decline 6.7% to SAR 86.1 million in Q4 2024 from SAR 92.4 million in Q4 2023, according to estimates by four research firms.
Quarterly Actuals vs Estimates (M Riyal)
Average Estimate (M Riyal)
Analyst | Million Riyals |
---|---|
SNB Capital Company | 96.10 |
Osool and Bakheet Investment Co. | 90.40 |
United Securities Company | 82.00 |
Riyad Capital | 76.00 |
Average | 86.13 |
Net Profit Before Unusual Items (2023 - Q4) | 92.35 |
Change % | (6.74%) |
Performance and Profitability Indicators
The following table shows the stock performance and P/E ratio as well as the earnings per share trailing 12 months (TTM) and year to date (YTD):
Stock Performance
Item | The Company | TASI |
---|---|---|
YTD | (13.78 %) | 2.79 % |
Change(12M) | (38.99 %) | 3.24 % |
Previous Close | 78.80 | 12,414.40 |
P/E adjusted (x) | 18.68 | 24.92 |
EPS (TTM) before unusual items (SAR/Share) | 4.22 | - |
Comments {{getCommentCount()}}
Be the first to comment
{{Comments.indexOf(comment)+1}}
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}

Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.
Valuation Data (Latest Share Price)
P/E (TTM) | 16.45 |
P/E Before Unusual Items (TTM) | 16.45 |
P/BV | 4.17 |
Dividend Yield | 2.36 % |
Market Cap. (M) | 5,899.00 |
Return on Average Assets | 7.50 % |
Return on Average Equity | 12.01 % |
Most Read
Call Request
Comments Analysis: